The Role of Thrombophilia Factors Polymorphism and Cytogenetic Analysis in Recurrent Pregnancy Loss (RPL) in Northeastern Iran

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 117

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JOGCR-8-4_005

تاریخ نمایه سازی: 26 تیر 1402

Abstract:

Background & Objective: Recurrent pregnancy loss (RPL) is the occurrence of three or more miscarriages before the ۲۰th week of pregnancy. Thrombophilia factors are one of the common causes of RPL.Materials & Methods: This retrospective study was performed on women with miscarriages. ۶۲۰ patients’ documents with pregnancy loss were investigated. Based on the number of pregnancy loss, the women were divided into a control group with less than three miscarriages (۲۱۲) and RPL group (۱۸۰). Cytogenetics analysis and thrombophilia factors polymorphism tests were performed for all patients.Results: In the analysis, none of the studied polymorphisms (MTHFR ۶۷۷ C⁄T /Factor V Leiden /Prothrombin G۲۰۲۱۰A/ ACE I/D/ PAI-۱) showed a significant relationship between Control and RPL groups (P-value ˃ ۰.۰۵). Cytogenetic analysis showed ۲ numerical and ۹ structural abnormalities among both groups. Statistical analysis indicated a significant association between the number of abortions and age (P value= ۰.۰۰۵, r= ۰.۱۳۹). We even realized that there was a significant relationship between polymorphism number and recurrent number of miscarriages (P value= ۰.۰۱۸, r= ۰.۶).Conclusion: We showed that polymorphisms analysis for thrombophilia factors is a more precious test than cytogenetics analysis (study of the banded pattern of chromosomes during metaphase of the cell cycle). We even indicated that no association was found between thrombophilia polymorphisms in the control and RPL groups. This means that screening for Factor V Leiden, prothrombin G۲۰۲۱۰A, MTHFR C۶۷۷T, ACE I/D, and PAI-۱ and cytogenetic analysis in patients with a history of RPL is not recommended.

Authors

Mohammad Reza Javan

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran

Bahareh Moghimian-Boroujeni

Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Hossein Ayatollahi

Department of Hematopathology, Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Amirali Ayatollahi

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Nafise Amini

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Elham Jafaei

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Sheikhi

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Narjes Soltani

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ahangari N, Doosti M, Mousavifar N, Attaran M, Shahrokhzadeh S, ...
  • Nassour-Mokhtari I, Loukidi B, Moussouni A, Bettioui R, Benhabib R, ...
  • Hardy ML, Day ML, Morris MB. Redox Regulation and Oxidative ...
  • Soltani N, Mirzaei F, Ayatollahi H. Cytogenetic Study of Patients ...
  • Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, ...
  • Zahed LF, Rayes RF, Mahfouz RA, Taher AT, Maarouf HH, ...
  • نمایش کامل مراجع